Pfizer’s Face-Off With The US Treasury Edges Closer
This article was originally published in The Pink Sheet Daily
Executive Summary
The US Treasury issued additional guidance to deter corporate inversions, just weeks after Pfizer confirmed it is in tax-motivated merger discussions with Allergan.